Granahan Investment Management, LLC Esperion Therapeutics, Inc. Transaction History

Granahan Investment Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $1.41 Million - $3.5 Million	-293,766 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $445,877 - $840,247	-39,319 Reduced 11.8%	293,766 $3.54 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $333,001 - $492,807	17,165 Added 5.43%	333,085 $7.05 Million
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $3.38 Million - $4.96 Million	-134,478 Reduced 29.86%	315,920 $8.86 Million
Q4 2020 Feb 12, 2021	SELL	$24.2 - $35.76 $912,364 - $1.35 Million	-37,701 Reduced 7.72%	450,398 $11.7 Million
Q3 2020 Nov 12, 2020	BUY	$31.18 - $52.71 $5.5 Million - $9.29 Million	176,323 Added 56.55%	488,099 $18.1 Million
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $2.44 Million - $4.17 Million	81,322 Added 35.29%	311,776 $16 Million
Q1 2020 May 12, 2020	SELL	$27.44 - $73.84 $1.51 Million - $4.05 Million	-54,873 Reduced 19.23%	230,454 $7.27 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $4.63 Million - $7.82 Million	130,699 Added 84.52%	285,327 $17 Million
Q3 2019 Nov 15, 2019	BUY	$34.47 - $47.53 $5.33 Million - $7.35 Million	154,628 New	154,628 $5.67 Million
Q1 2019 May 14, 2019	SELL	$40.11 - $53.57 $4.34 Million - $5.8 Million	-108,200 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$36.99 - $59.11 $120,217 - $192,107	-3,250 Reduced 2.92%	108,200 $4.98 Million
Q3 2018 Nov 13, 2018	BUY	$40.74 - $51.41 $167,034 - $210,781	4,100 Added 3.82%	111,450 $4.95 Million
Q2 2018 Aug 15, 2018	BUY	$36.2 - $76.4 $3.89 Million - $8.2 Million	107,350 New	107,350 $4.21 Million

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $149M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.